Eventide Asset Management, LLC

SEC CIK: 0001442891
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

TPTX holding history

Turning Point Therapeutics, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TPTX overview All 13F holders of TPTX Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of TPTX by Eventide Asset Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−578,000−100.0%	Sold out	Holders
Q3 2021	578,000	$38.4M	0.5%	00.0%	Unchanged	Holders
Q2 2021	578,000	$45.1M	0.6%	+73,000+14.5%	Added	Holders
Q1 2021	505,000	$47.8M	0.7%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.